Statins and the risk of bleeding in patients taking dabigatran.

Bo-Lin Ho,Ya-Ju Lin,Sheng-Feng Lin,Ping-Song Chou,Chien-Fu Chen,Ruey-Tay Lin,Han-Hwa Hu,A-Ching Chao

ACTA NEUROLOGICA SCANDINAVICA（2019）

引用 9|浏览0

暂无评分

摘要

For secondary prevention of stroke in patients with NVAF who are taking dabigatran etexilate, co-prescription with a statin was associated with a lower risk of bleeding complications. Future research is needed to determine the pharmacological mechanism underlying this effect. This article is protected by copyright. All rights reserved.

查看译文

关键词

Anticoagulant,atrial fibrillation,bleeding,co-medication,dabigatran,statin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要